Premarket Gainers as of 9:05 am (03/14/2018)

RFIL +51% on Q1 result.

RKDA +44% on achieving key resistant starch wheat technology milestones, prepares for commercial launch.

TYME +22% as FDA has accepted its investigational new drug application allowing to initiate the planned Phase II clinical trial for SM-88 in pancreatic cancer.

KOOL +9% as Cesca inks deal in Asia for CAR-T cell processing services.

OTIV +6% on new purchase order to deliver 8,000 of OTI"s Uno-advanced 8 secure contactless NFC readers to the Smart ATM market.

EXPR +5% on Q4 result.

ALOT +5% on Q4 result.